> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Fraud, Abuse Landscape Changing: Review
- URL: https://www.fdaweb.com/fraud-abuse-landscape-changing-review/
- Published: 2016-03-17T12:00:00.000Z
- Updated: 2026-09-15T02:44:50.000Z
- Author: David McFarland
- Tags: Drugs, Devices, #legacy-id-D5135116

> The Bass Berry & Sims [2015 Healthcare Fraud and Abuse Review](http://www.lexology.com/library/detail.aspx?g=f97728fa-c269-40eb-ad2b-8f9f5a0e95e7&ref=fdaweb.com) says that only a fraction of the $3.6 billion in Fiscal Year 2015 civil fraud recoveries involved matters concerning the drug industry, while a significant amount of them involved whistleblower actions raising issues of medical necessity and improper financial relationships between hospitals and doctors. This was the 11th straight year in which recoveries exceeded $1 billion, the report says.  
>  
> It notes that the year’s fraud headlines were noteworthy as much for legal developments and Justice Department pronouncements as for the healthcare fraud recovery amount.  
>  
> Although 2015 was the fifth straight year in which whistleblowers filed more than 600 new lawsuits, the yearly total of 632 new suits was more than 10% lower than in the previous year. Whistleblowers recovered a record-breaking $598 million as their share of the proceeds in *qui tam* judgments and settlements in FY 2015.  
>  
> The report also references the 9/2015 “Yates Memo” in which deputy attorney general **Sally Yates** formalized a message that department officials have forecasted for several years: that it will seek to hold individuals who are responsible for corporate wrongdoing accountable for their actions.  
>  
> Details in the report cover a number of cases involving FDA.